Author:
Dongre Yashavantha,Mahadevappa B.,Rohini R.
Abstract
PurposeThe purpose of this paper is to evaluate the possibility of marketing specific low‐cost drugs across segmented markets in India.Design/methodology/approachThe study is empirical in nature, based on the primary data gathered through actual field survey. The study analyzes the attitudes, perceptions and experiences of five stockists, 50 physicians and 100 patients drawn from 20 healthcare organizations from different parts of the State of Karnataka in India.FindingsThe survey findings revealed that patients would be happy and would have better access to medicine if the same is offered at a lower price. Doctors are willing to prescribe generic drugs. Generic drug market has good economic feasibility. At present, the consumption of generic drugs to branded drugs in hospitals is found to be in the ratio 2:3 while for the stockist it is in the ratio 1:2. The study also revealed the fact that patients prefer to take generic medicines mostly on the basis of physicians' advice. They do consider cost but generally go by the prescriptions of the doctors.Practical implicationsPrescribing generic drugs would definitely contribute to greater use of medicine by the rural poor and thus better health conditions in rural areas. Low‐cost medicine is an opportunity for pharmaceutical companies because consumers of healthcare are increasingly concerned with the quality and the cost of drugs that they buy. This research enhances sales and marketing management in terms of creating awareness of the importance of doctors' perceptions. Healthcare providers would benefit from the findings of this paper.Originality/valueAs the generic drug market encompasses a variety of healthcare professionals and users, this paper establishes a practical methodology to have an understanding about the attitudes, perceptions and experiences of stockists, physicians and patients regarding the usage of such low‐cost drugs.
Reference19 articles.
1. Banahan, B. and Kolassa, E. (1997), “A physician's survey on generic drugs and substitution of critical dose medications”, Archives of Internal Medicine, Vol. 157 No. 18, pp. 2080‐8.
2. Basak, S.C. (2005), “Changes in India's patent regime and access to medicine”, available at: www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=28721§ionid=46 (accessed 1 September 2010).
3. Creyer, E.H., Hrsistodoulakis, I. and Cole, C.A. (2001), “Changing a drug from Rx to OTC status: the consumer behavior and public policy implications of switch drugs”, Journal of Product & Brand Management, Vol. 10 No. 1, pp. 52‐64.
4. Department of Chemicals and Petrochemicals (2008), “Pharmaceuticals”, available at: http://chemicals.nic.in/pharma1.htm (accessed 16 September 2010).
5. Gholamreza, S. and Meimandi, M.‐S. (2005), “The quality of prescribing in general practice in Kerman, Iran”, International Journal of Health Care Quality Assurance, Vol. 18 No. 5, pp. 353‐60.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献